ROP — Roche Holding AG Share News
0.000.00%
Last trade - 00:00- CH₣254.44bn
- CH₣276.23bn
- CH₣61.52bn
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza
Factbox: Global drugmakers invest billions to boost US presence
Brief: Roche Says Receives FDA Approval For The First Companion Diagnostic To Assess PTEN Protein In People Living With Prostate Cancer
Jazz Pharmaceuticals lung cancer drug fails main trial goal (updated)
Swiss pharma hub Basel frets over population cap threat
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Brief: Roche - FDA Grants Priority Review For Tecentriq For A Certain Type Of Stage III Colon Cancer
Organon wins US approval to widen use of arthritis biosimilar drug
Focus: Lilly stays ahead of the pack as rivals jump on obesity drug bandwagon
Samsung Elec invests $175 million to become top shareholder in US genetics firm (updated)
Focus: Cancer vaccines based on mRNA advance, despite US cuts (updated)
Samsung Electronics invests $175 million in Element Biosciences' Series E funding round
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
IDEAYA Biosciences drops on $300 mln equity raise
Focus: Cancer vaccines based on mRNA advance, despite US cuts
Roche sticks to German investment after Eli Lilly cuts